Kumar Rakhi
SEC CIK 1856296 · EDGAR
BoughtSold
Most active insiders at NPCE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Morrell Martha | Chief MEDICAL Off | — | $399.2K |
| 2 | Kumar Rakhi | Dir | — | — |
| 3 | Ryan Renee | Dir | — | — |
| 4 | Andrade Lisa | Dir | — | — |
| 5 | Williams Patrick F. | CFO | — | — |
| 6 | Becker Joel | CEO, Dir | — | — |
| 7 | Geiger Uri | Dir | — | — |
| 8 | Huennekens R Scott | Dir | — | — |
| 9 | Fischer Frank M | Dir | — | — |
| 10 | LACOB JOSEPH | Dir | — | — |
Transactions 70
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 16:32 | 2026-06-19 | NPCE | NeuroPace Inc | Kumar Rakhi | Dir | A - Grant | $15.63 | +989 | 23.0K | +4% | +$15.5K | |
| D | 2026-06-05 17:10 | 2026-06-05 | NPCE | NeuroPace Inc | Kumar Rakhi | Dir | A - Grant | $0.00 | +2,890 | 22.1K | +15% | $0 |
| 2026-03-23 | 2026-03-20 | NPCE | NeuroPace Inc | Kumar Rakhi | Dir | A - Grant | $13.00 | +1,153 | 19.2K | +6% | +$15.0K | |
| 2025-12-23 | 2025-12-19 | NPCE | NeuroPace Inc | Kumar Rakhi | Dir | A - Grant | $16.59 | +904 | 18.0K | +5% | +$15.0K | |
| 2025-09-22 | 2025-09-19 | NPCE | NeuroPace Inc | Kumar Rakhi | Dir | A - Grant | $9.94 | +1,509 | 17.1K | +10% | +$15.0K | |
| M | 2025-06-24 | 2023-06-30+ | NPCE | NeuroPace Inc | Kumar Rakhi | Dir | A - Grant | $8.65 | +15.6K | 14.2K | New | +$134.9K |
| 2025-02-24 | 2025-02-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $10.72 | -958 | 162.3K | -0.6% | -$10.3K | |
| D | 2025-02-18 | 2025-02-13 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | $3.85 | +187.5K | 390.8K | +92% | +$721.9K |
| D | 2025-02-18 | 2025-02-13 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale+OE | $10.43 | -227.5K | 163.3K | -58% | -$2.37M |
| 2025-01-22 | 2025-01-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.15 | -1,057 | 203.3K | -0.5% | -$11.8K | |
| 2024-12-26 | 2024-12-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.57 | -3,087 | 204.3K | -1% | -$35.7K | |
| 2024-11-22 | 2024-11-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.49 | -958 | 207.4K | -0.5% | -$11.0K | |
| 2024-10-22 | 2024-10-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.92 | -956 | 208.4K | -0.5% | -$11.4K | |
| DT | 2024-09-24 | 2024-09-23 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | $3.85 | +250.0K | 459.3K | +119% | +$962.5K |
| DT | 2024-09-24 | 2024-09-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.97 | -3,087 | 209.3K | -1% | -$37.0K |
| DT | 2024-09-24 | 2024-09-23 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale+OE | $11.89 | -250.0K | 209.3K | -54% | -$2.97M |
| T | 2024-08-22 | 2024-08-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.48 | -958 | 212.4K | -0.4% | -$11.0K |
| T | 2024-07-25 | 2024-07-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.00 | -958 | 213.4K | -0.4% | -$10.5K |
| T | 2024-06-24 | 2024-06-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $10.80 | -3,087 | 212.1K | -1% | -$33.3K |
| T | 2024-05-22 | 2024-05-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.37 | -1,363 | 215.2K | -0.6% | -$15.5K |
| D | 2024-04-24 | 2024-04-22 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | A - Grant | $0.00 | -38.7K | 216.6K | -15% | $0 |
| T | 2024-04-23 | 2024-04-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $10.46 | -9,881 | 177.9K | -5% | -$103.4K |
| T | 2024-03-22 | 2024-03-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $10.01 | -1,506 | 187.8K | -0.8% | -$15.1K |
| T | 2024-02-22 | 2024-02-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.54 | -1,508 | 189.3K | -0.8% | -$17.4K |
| T | 2024-01-23 | 2024-01-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $10.35 | -1,506 | 190.8K | -0.8% | -$15.6K |
| DT | 2023-12-29 | 2023-12-27 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | — | +13 | 192.3K | +0.0% | — |
| DT | 2023-12-29 | 2023-12-27 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $11.58 | -6 | 192.3K | -0.0% | -$69.48 |
| T | 2023-12-22 | 2023-12-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $9.96 | -1,364 | 192.3K | -0.7% | -$13.6K |
| T | 2023-11-27 | 2023-11-22 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $8.68 | -1,415 | 193.6K | -0.7% | -$12.3K |
| T | 2023-10-26 | 2023-10-24 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $8.99 | -1,563 | 195.1K | -0.8% | -$14.1K |
| D | 2023-09-29 | 2023-09-28 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $12.67 | -92 | 196.6K | -0.0% | -$1,166 |
| D | 2023-09-29 | 2023-09-27 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | — | +169 | 196.7K | +0.1% | — |
| 2023-09-26 | 2023-09-22 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $10.19 | -1,403 | 196.5K | -0.7% | -$14.3K | |
| D | 2023-09-12 | 2023-09-08 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | $6.48 | +99.3K | 297.3K | +50% | +$643.8K |
| D | 2023-09-12 | 2023-09-08 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale+OE | $12.18 | -99.3K | 197.9K | -33% | -$1.21M |
| D | 2023-09-07 | 2023-09-05 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | $6.48 | +1,724 | 199.7K | +0.9% | +$11.2K |
| D | 2023-09-07 | 2023-09-05 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale+OE | $12.00 | -1,724 | 197.9K | -0.9% | -$20.7K |
| 2023-08-24 | 2023-08-22 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $10.83 | -1,378 | 197.9K | -0.7% | -$14.9K | |
| DM | 2023-08-03 | 2023-08-01+ | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale+OE | $12.00 | -4,017 | 199.3K | -2% | -$48.2K |
| DM | 2023-08-03 | 2023-08-01+ | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | $6.48 | +4,017 | 203.0K | +2% | +$26.0K |
| 2023-07-26 | 2023-07-24 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $10.99 | -1,393 | 199.3K | -0.7% | -$15.3K | |
| DM | 2023-07-18 | 2023-07-14+ | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | $6.48 | +635 | 82.7K | +0.8% | +$4,115 |
| DM | 2023-07-18 | 2023-07-14+ | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale+OE | $12.00 | -635 | 82.1K | -0.8% | -$7,620 |
| 2023-06-26 | 2023-06-22 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $10.01 | -1,357 | 197.2K | -0.7% | -$13.6K | |
| D | 2023-06-13 | 2023-06-09 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | $5.12 | +43.9K | 242.5K | +22% | +$224.7K |
| D | 2023-06-13 | 2023-06-09 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale+OE | $9.93 | -43.9K | 198.6K | -18% | -$435.9K |
| 2023-05-25 | 2023-05-23 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $9.58 | -1,557 | 198.6K | -0.8% | -$14.9K | |
| DMT | 2023-05-03 | 2023-05-01+ | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | $3.85 | +77.7K | 215.7K | +56% | +$299.3K |
| DMT | 2023-05-03 | 2023-05-01+ | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale+OE | $8.55 | -77.7K | 200.1K | -28% | -$664.5K |
| DMT | 2023-04-28 | 2023-04-26+ | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | M - OptEx | $3.88 | +230.8K | 288.0K | +404% | +$895.6K |
| DMT | 2023-04-28 | 2023-04-26+ | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale+OE | $8.56 | -230.8K | 200.1K | -54% | -$1.98M |
| D | 2023-04-24 | 2023-04-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $8.80 | -1,569 | 200.1K | -0.8% | -$13.8K |
| D | 2023-04-24 | 2023-04-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | A - Grant | $0.00 | +66.7K | 201.7K | +49% | $0 |
| 2023-03-27 | 2023-03-23 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $7.30 | -2,134 | 130.4K | -2% | -$15.6K | |
| 2023-02-24 | 2023-02-22 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $8.43 | -1,797 | 132.5K | -1% | -$15.1K | |
| 2023-01-26 | 2023-01-24 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $8.56 | -1,838 | 134.3K | -1% | -$15.7K | |
| 2022-12-28 | 2022-12-23 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $7.10 | -1,592 | 136.2K | -1% | -$11.3K | |
| 2022-11-22 | 2022-11-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | J - Other | $5.00 | -1,584 | 137.8K | -1% | -$7,920 | |
| 2022-10-27 | 2022-10-25 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $4.40 | -1,588 | 139.4K | -1% | -$6,987 | |
| 2022-09-27 | 2022-09-23 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $3.07 | -1,741 | 140.9K | -1% | -$5,345 | |
| 2022-08-26 | 2022-08-24 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $3.71 | -1,652 | 142.7K | -1% | -$6,129 | |
| 2022-07-27 | 2022-07-25 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $4.33 | -1,686 | 144.3K | -1% | -$7,300 | |
| 2022-06-27 | 2022-06-23 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $4.34 | -1,635 | 146.0K | -1% | -$7,096 | |
| 2022-05-24 | 2022-05-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $3.70 | -12.1K | 147.7K | -8% | -$44.9K | |
| 2022-04-27 | 2022-04-25 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $3.84 | -703 | 159.8K | -0.4% | -$2,700 | |
| 2022-04-01 | 2022-03-30 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | F - Tax | $4.74 | -2,077 | 160.5K | -1% | -$9,845 | |
| 2022-04-01 | 2022-03-30 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $4.84 | -2,486 | 162.6K | -2% | -$12.0K | |
| 2022-03-29 | 2022-03-25 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $5.06 | -7,281 | 165.0K | -4% | -$36.8K | |
| 2022-03-22 | 2022-03-18 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $5.13 | -2,153 | 172.3K | -1% | -$11.0K | |
| 2022-03-09 | 2022-03-07 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | CAO | S - Sale | $5.52 | -3,091 | 174.5K | -2% | -$17.1K |
Purchase Sale Sale after option exercise All abbreviations